Clarify the Role of Ongentys and Kynmobi for Parkinson's Disease

Opicapone (Ongentys) and sublingual apomorphine (Kynmobi) will add to the growing list of new meds for Parkinson's disease.

They're for "off" episodes...when symptoms (tremor, etc) return between carbidopa/levodopa doses, especially as Parkinson's progresses.

Opicapone is an oral COMT inhibitor similar to entacapone.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals